CompletedPHASE2, PHASE3NCT00005007

Etanercept for Wegener's Granulomatosis

Studying Vasculitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Principal Investigator
John H. Stone, MD, MPH, MD, MPH
Johns Hopkins University
Intervention
Etanercept(drug)
Enrollment
181 enrolled
Eligibility
11 years · All sexes
Timeline
20002003

Study locations (8)

Collaborators

FDA Office of Orphan Products Development

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00005007 on ClinicalTrials.gov

Other trials for Vasculitis

Additional recruiting or active studies for the same condition.

See all trials for Vasculitis

← Back to all trials